Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, September 12, 2024.
| Ticker |
Sentiment |
Impact |
|
GIC
|
Neutral
|
4 %
|
|
SNY
|
Somewhat Bullish
|
36 %
|
